We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Advice and guidance on the health needs of migrant patients for healthcare practitioners.
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (7 March 2024) approved the medicine rozanolixizumab (Rystiggo) to treat adults with generalised myasthenia gravis, an autoimmune disease that causes muscle weakness, which can affect multiple muscle groups throughout the...
Advice to help lower the chance of passing mpox infection to others during post-exposure vaccination clinics.
Public health principles for reducing the spread of respiratory infections, including COVID-19, in the workplace.
Advice for medical professionals to follow when assessing drivers with neurological disorders.
Guidance for people with symptoms of a respiratory infection including COVID-19, or a positive test result for COVID-19.
You must tell DVLA if you have muscular dystrophy - download the correct form to let them know.
These documents explain how OHID is approaching reduction and food and drink reformulation as part of the government’s obesity strategy.
Employers guide to assessing fitness to work, including asking for medical evidence, fit notes, and dealing with long term or frequent absences.
Today (Thursday 3rd June), hundreds of tiny worms are being flown to the International Space Station (ISS) as part of an experiment to understand more about human muscle loss and how to prevent it.
Use the online service or postal form to apply to reduce your Self Assessment payments on account.
We inform healthcare professionals of new risk minimisation measures for JAK inhibitors used to treat chronic inflammatory disorders, consistent with the measures introduced for tofacitinib (Xeljanz) in 2020 and 2021. This advice affects abrocitinib (Cibinqo▼), baricitinib (Olumiant), upadacitinib (Rinvoq▼), and...
Check if you need to tell DVLA about a health or medical condition, how to report medical conditions to DVLA
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.